USC.edu
Are you a Patient?

Robert Holloway, MD

Clinical Associate Professor of Psychiatry & the Behavioral Sciences, Pediatrics, and Anesthesiology (Clinician Educator)

Image of Robert Holloway, MD
Is this your profile? Click to edit
Email roholloway@chla.usc.edu
CTSI Profile

Publications

  • A Remote Longitudinal Observational Study of Individuals at Genetic Risk for Parkinson Disease: Baseline Results Neurol Genet. 2022 Oct; 8(5):e200008. . View in PubMed
  • A Virtual Cohort Study of Individuals at Genetic Risk for Parkinson’s Disease: Study Protocol and Design J Parkinsons Dis. 2020; 10(3):1195-1207. . View in PubMed
  • Neurologists as primary palliative care providers: Communication and practice approaches Neurol Clin Pract. 2016 Feb; 6(1):40-48. . View in PubMed
  • The lack of documentation of preferences in a cohort of adults who died after ischemic stroke Neurology. 2016 05 31; 86(22):2056-62. . View in PubMed
  • Racial/Ethnic differences in process of care and outcomes among patients hospitalized with intracerebral hemorrhage Stroke. 2014 Nov; 45(11):3243-50. . View in PubMed
  • Cost of deep brain stimulation for the treatment of Parkinson’s disease by surgical stimulation sites Mov Disord. 2014 Nov; 29(13):1666-74. . View in PubMed
  • Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson’s disease Mov Disord. 2014 Feb; 29(2):169-76. . View in PubMed
  • Parkinson’s disease medication use and costs following deep brain stimulation Mov Disord. 2012 Sep 15; 27(11):1398-403. . View in PubMed
  • Sham surgery controls in Parkinson’s disease clinical trials: views of participants Mov Disord. 2012 Sep 15; 27(11):1461-5. . View in PubMed
  • Comparison of enrollees and decliners of Parkinson disease sham surgery trials Mov Disord. 2012 Apr; 27(4):506-11. . View in PubMed
  • Patient and organizational factors related to education and support use by Veterans with Parkinson’s disease Mov Disord. 2009 Oct 15; 24(13):1916-24. . View in PubMed
  • Effects of gabapentin on sleep in menopausal women with hot flashes as measured by a Pittsburgh Sleep Quality Index factor scoring model J Womens Health (Larchmt). 2009 Sep; 18(9):1355-60. . View in PubMed
  • Funding of Parkinson research from industry and US federal and foundation sources Mov Disord. 2009 Apr 15; 24(5):731-7. . View in PubMed
  • Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results Mov Disord. 2008 Nov 15; 23(15):2129-70. . View in PubMed
  • Ethics of sham surgery: perspective of patients Mov Disord. 2008 Jan; 23(1):63-8. . View in PubMed
  • Risk factors for somnolence, edema, and hallucinations in early Parkinson disease Neurology. 2007 Jul 10; 69(2):187-95. . View in PubMed
  • Health care costs decline after successful epilepsy surgery Neurology. 2007 Apr 17; 68(16):1290-8. . View in PubMed
  • Accuracy of Medicare claims data in identifying Parkinsonism cases: comparison with the Medicare current beneficiary survey Mov Disord. 2007 Mar 15; 22(4):509-14. . View in PubMed
  • Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan Mov Disord. 2007 Jan; 22(1):41-7. . View in PubMed
  • Economic burden associated with Parkinson’s disease on elderly Medicare beneficiaries Mov Disord. 2006 Mar; 21(3):362-72. . View in PubMed
  • Pramipexole versus levodopa in patients with early Parkinson’s disease: effect on generic and disease-specific quality of life Value Health. 2006 Jan-Feb; 9(1):28-38. . View in PubMed
  • Pramipexole vlevodopa as initial treatment for Parkinson’s disease: a randomized clinical-economic trial. Med Decis Making. 2004 Sep-Oct; 24(5):472-85. . View in PubMed
  • Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations Mov Disord. 2004 Sep; 19(9):1020-8. . View in PubMed
  • Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial Arch Neurol. 2004 Jul; 61(7):1044-53. . View in PubMed
  • Development and testing of the Parkinson’s disease quality of life scale Mov Disord. 2003 Jun; 18(6):637-45. . View in PubMed
  • Neurologists’ use of ICD-9CM codes for dementia Neurology. 2001 May 08; 56(9):1206-9. . View in PubMed
  • Cost-effectiveness analysis in Parkinson’s disease: determining the value of interventions Mov Disord. 2000 May; 15(3):439-45. . View in PubMed
  • Carotid endarterectomy trends in the patterns and outcomes of care at academic medical centers, 1990 through 1995 Arch Neurol. 1998 Jan; 55(1):25-32. . View in PubMed

Similar People